Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
FungiXpert Cryptococcal Antigen Rapid Test Successfully Approved by Health Canada
We are pleased to announce that our Cryptococcal Capsular Polysaccharide Detection K-Set (Lateral Flow Assay) has b...
Work Tenaciously, Pursuit Excellence
Genobio Tries to Be a Brave Pathpaver
On December 5th,2015, the marketing management team of Era Biology held an outdoor training.
Every member of this team nee...
Day 2 at ISHAM 2022
New Delhi, India – September 21, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Society for Human and Animal Mycology (IS...
Invasive candidiasis is a frequent life-threatening complication in critically ill patients. Early diagnosis followed by prompt treatment aimed at improving outcome by minimizing unnecessary antifu...
These series of methods are assays by utilizing specific viral antigen to detect antibodies in patients’ serum, including IgM antibodies detection and IgG antibodies measurement. The IgM antibodies...